Scienmag

FEBRUARY 19, 2021

Anaylsis shows different genetic risk landscape for IBD In African Americans, the genetic risk landscape for inflammatory bowel disease (IBD) is very different from that of people with European ancestry, according to results of the first whole-genome study of IBD in African Americans.

Genome 50

Genome Genomics Genetics Clinical Research 50

Medical Xpress

NOVEMBER 21, 2022

In a new study published in Circulation: Genomics & Precision Medicine, Mayo Clinic researchers designed and developed the first suppression-replacement KCNH2 gene therapy for correcting both long QT syndrome (LQTS) and short QT syndrome (SQTS).

Gene Therapy 67

Gene Therapy Gene Genome Genomics 67

Medical Xpress

DECEMBER 29, 2022

A clinical research team from the University of Hong Kong (HKUMed) has used amniotic fluid cells obtained during 16-24 weeks of pregnancy as a novel sample type for RNA-sequencing in prenatal diagnosis to help more families with tailored clinical management.

RNA 75

RNA Genome Genomics Clinical Research 75

pharmaphorum

JANUARY 18, 2023

However, the Resilience Project’s scientists had used genomic data originally collected for other studies and, due to limitations in the original studies’ informed consent policies and a lack of infrastructure to recontact participants, none of the 13 individuals could be contacted with follow-up questions or requests.

Genetic Disease 97

Genetic Disease Genetics Research Genome 97

pharmaphorum

DECEMBER 21, 2021

In a recent webinar held by pharmaphorum, in partnership with IQVIA, a discussion was held looking at how to make academic and commercial medical research more efficient, while also looking at the opportunity of genomic data to bring benefits to patients and healthcare systems. The potential to leverage genomic data.

Development 98

Development Genome Genomics Drugs 98

Drug Discovery World

MAY 30, 2024

This is an established test in the clinic. In research, it allows us to directly study vaccine-responsive cells, for example their genomic composition and protein expression. She read medicine at the University of Cambridge and Imperial College London before training as a clinician scientist.

Vaccination 59

Vaccination Vaccine Scientist Clinical Trials 59

pharmaphorum

APRIL 23, 2020

You can listen to our March webinar here: [link] Focus During the April instalment, our expert panel will discuss: •Assessing the pharmaceutical market impact of COVID-19 •The UK clinical trials on COVID-19: navigating uncharted waters •Genomics: research in the time of COVID-19 •Knowledge sharing: the COVID-19 experience from a US perspective •Getting (..)

Genome 40

Genome Genomics Life Science Clinical Trials 40

pharmaphorum

SEPTEMBER 16, 2022

Essentially, the collaboration brought together both “the right expertise and the right technology”, opening up myriad possibilities for targeting GPCRs within the human genome. Kim recognised then, he said, that better tools for medicine needed to be developed, and that they still do. What, then, is the solution?

Development 135

Development Research Drugs Clinical Trials 135

XTalks

MAY 20, 2022

Doctors and physicians rely on the results provided by a clinical scientist to make an accurate prognosis, diagnosis and assessment for a patient’s treatment plan. What is it Like to Work as a Clinical Scientist? A clinical scientist is often synonymous with: Clinical Research / Clinical Laboratory Scientist.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

pharmaphorum

SEPTEMBER 12, 2022

Alongside drugs and therapeutics, data collection and technology enhancements have redefined the traditional healthcare experience, especially within oncology, and genomic profiling has become a significant factor in allowing for personalised care. Tailored oncology. In other words, every person’s cancer has its own genetic construct.

Genome 106

Genome Genomics Clinical Trials Clinical Trials 106

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Thus, she belongs to the Center for Medical Informatics at the University Medicine Dresden.

Genome 106

Genome Genomics Research Medicine 106

XTalks

MAY 23, 2024

With over 25 years of experience, Dr. Duke’s expertise in growth and bone disorders has been instrumental in advancing clinical research and improving patient outcomes. Advancements in genomic technology, precision medicine and gene therapy offer hope for personalized treatments and improved outcomes.

Clinical Trials 52

Clinical Trials Clinical Trials Hormones Trials 52

pharmaphorum

NOVEMBER 27, 2022

A group representing pharma companies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targeted drugs. The post Genomic testing ‘should be offered to all cancer patients in Scotland’ appeared first on. Why not lead?”

Genome 104

Genome Genomics Genetics Medicine 104

pharmaphorum

FEBRUARY 10, 2022

CVS will harness Medable’s decentralised trials software, deploying it in thousands of CVS MinuteClinics across the US, to create a network that could unlock access to clinical research studies for millions of Americans, according to the healthcare group.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Pharmacy 52

Drug Discovery World

OCTOBER 16, 2023

Indeed, this is bolstered by top tier universities like Newcastle University, which specialises in structure-based approaches for drug discovery, developing innovative technologies that support the identification of new medicines, and is well-established in cancer drug discovery. Government investment of £1.3

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

MAY 19, 2022

“If the European Health Data Space (EHDS) and the rules surrounding access to the data are not carefully thought through, with the involvement of all stakeholders, there could be unintended consequences that limit the utility of the data for developing innovative medicines,” said the organisation. Huge potential. Significant challenges.

Genome 52

Genome Genomics Medicine Research 52

Drug Discovery World

APRIL 14, 2023

Carl H June, MD, FAACR – Lifetime Achievement in Cancer Research June, a Fellow of the AACR Academy, is the Richard W Vague Professor in Immunotherapy, Director of the Center for Cellular Immunotherapies, and Director of the Parker Institute for Cancer Immunotherapy in the Perelman School of Medicine at the University of Pennsylvania.

Genetics 52

Genetics Research Medicine Clinical Research 52

pharmaphorum

MARCH 10, 2022

“That includes supporting public and patient involvement (PPI), thinking about diversity and inclusion, and what happens to the outputs of research.”. All these elements contribute to better research, better science, and better medicines, she went on. “In That’s where initiatives like the Open Research platform come in.

Research 97

Research Genome Genomics Clinical Trials 97

The Pharma Data

JANUARY 17, 2021

The service is expected to become operational in 2021 and will be available for clinical research and clinical care — starting with private patients, followed by expansion into the public healthcare system over time. “We Guardant Health has achieved CE mark approval as well as U.S.

Genome 40

Genome Genomics Clinical Trials Clinical Trials 40

Advarra

NOVEMBER 29, 2022

The field of cell and gene therapies (CGT) is constantly evolving, and there has been significant progress in this area of research. However, despite the promise of these therapies, the regulations governing them lag the science, which in turn hinders the clinical translation of these novel medicines.

Gene Therapy 52

Gene Therapy Gene Production Clinical Trials 52

The Pharma Data

NOVEMBER 5, 2020

Pellegrini is a professor at the University of Modena and Reggio Emilia, Cell Therapy Program Coordinator at the Centre for Regenerative Medicine “Stefano Ferrari”, and co-founder and R&D Director at Holostem Terapie Avanzate S.r.l. Prior to joining Synlogic, she served as COO for Pfizer’s Inflammation and Immunology Research Unit.

Genome 40

Genome Genomics Medicine Life Science 40

Drug Discovery World

NOVEMBER 8, 2023

AI’s role in drug discovery One notable example of AI’s role in clinical trials is a significant breakthrough made by researchers at the University of Toronto 3 in partnership with Insilico Medicine in discovering a potential drug for liver cancer. AI Tool Decodes Brain Cancer’s Genome During Surgery.

Clinical Trials 72

Clinical Trials Clinical Trials Trials Drugs 72

Roots Analysis

MARCH 24, 2022

Scientific fields involved in high throughput measurement of biological molecules are referred with the suffix- omics including, transcriptomics, genomics, proteomics and metabolomics. Genomics is the study of genetic material within a cell, and transcriptomics is the study of gene activity in different cells. Web: [link].

Clinical Research 52

Clinical Research Development Research Drug Delivery Systems 52

pharmaphorum

FEBRUARY 10, 2022

We know that digital transformation has the potential to rewrite the boundaries of the possible in medicine. In recent years, concepts including AI-led candidate selection, centralised clinical data monitoring, online sales, and virtual consultations have moved into primetime, all with the promise of making workflows more efficient.

Life Science 106

Life Science Genome Genomics Research 106

pharmaphorum

JULY 7, 2021

Again, our sector will be central to achieving this, not only in supporting investment in jobs across the country, but in getting new medicines and treatments to patients in all parts of the UK. This leads us to another one of the government’s core ambitions – to ‘level up’ the UK.

Life Science 59

Life Science Manufacturing Genome Genomics 59

Drug Discovery World

MAY 11, 2023

Published in Proceedings of the National Academy of Sciences , the research was led by UdeM medical professor Michel Cayouette, Director of Cellular Neurobiology Research at the UdeM-affiliated Montreal Clinical Research Institute.

Gene Therapy 52

Gene Therapy Gene Research Scientist 52

XTalks

APRIL 24, 2023

According to Dr. Melanie Blank, clinical team leader for General Medicine Branch 1 at the US Food and Drug Administration’s (FDA) Division of Clinical Evaluation and Pharmacology/Toxicology (DCEPT), the agency is seeing one or two new applications coming in every week for new gene therapies for different diseases.

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

XTalks

MAY 23, 2024

Eterovic brings much knowledge and experience to the table, having led the development of a new Oncology Diagnostic program at Eurofins Viracor that integrates the latest genomic profiling techniques. Eterovic highlights that the financial and logistical barriers to comprehensive genomic profiling are high but not impossible to overcome.

Genetics 114

Genetics Research Genome Genomics 114

pharmaphorum

OCTOBER 7, 2021

However, developments in genomic medicine are making huge strides to improve this situation, and these will also be discussed during the webinar. A board-certified paediatric haematologist/oncologist, Jeff has 12 years of academic faculty experience at the Johns Hopkins University School of Medicine. About IQVIA.

Genome 98

Genome Genomics Medicine Life Science 98

Drug Discovery World

MAY 17, 2024

Deepika Khedekar , Associate Centralized Clinical Trial Lead at IQVIA Inc, looks at the challenges of utilising artificial intelligence (AI) in oncology clinical research. That brings us to our next question – so what problems can AI solve in oncology research? National Human Genome Research Institute.

Trials 59

Trials Clinical Trials Clinical Trials Protein 59

The Pharma Data

JANUARY 10, 2021

11, 2021 (GLOBE NEWSWIRE) — Editas Medicine, Inc. Nasdaq: EDIT), a leading genome editing company, today announced the U.S. Food and Drug Administration (FDA) has cleared the initiation of the safety phase of the Company’s EDIT-301 clinical trial, and the Company can begin dosing patients. CAMBRIDGE, Mass.,

Medicine 52

Medicine Development Clinical Trials Clinical Trials 52

Drug Discovery World

JULY 12, 2023

This paid-for advertorial by BC Platforms appeared in DDW Volume 24 – Issue 3, Summer 2023 The use of real-world data (RWD) is demonstrating significant potential to enhance rare and orphan disease clinical research and development. How can researchers gain access to rare and orphan disease patient data, including RWD?

Research 52

Research Genome Genomics Clinical Trials 52

XTalks

NOVEMBER 7, 2022

These tumor-derived entities are used to derive genomic and proteomic data. The leaders in this space now are Foundation Medicine and Guardant360, which have a large number of FDA-approved companion diagnostic assays for different indications,” said Dr. Bahassi. TruSight Oncology 500 ctDNA (Illumina; in-house solution).

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

The Pharma Data

MARCH 11, 2021

Additionally, Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company, will present preclinical characterization data for an oral selective estrogen receptor degrader (SERD), BCL2 inhibitor, next-generation KRAS-G12C inhibitor, and next-generation RET inhibitor. Session Type: Clinical Trials Minisymposium.

Research 52

Research Clinical Trials Clinical Trials Trials 52

pharmaphorum

MAY 18, 2022

Genomics has unlocked entirely new insights to what exactly may cause certain neurological conditions. Because it takes decades of clinical research and investment to, hopefully, conquer widespread diseases like Alzheimer’s and Parkinson’s, we decided to collaborate in this area,” notes Charl. billion in 2021.

Gene Therapy 92

Gene Therapy Gene Genetics Development 92

XTalks

FEBRUARY 4, 2021

The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. This includes precision medicine strategies which can be effectively guided through high-level translational research led by clinical data.

Research 98

Research Biobanking Drugs Genome 98

Pharmaceutical Technology

FEBRUARY 26, 2023

These safety concerns froze research, says Dr. Sarah McGill, associate professor of medicine at the University of North Carolina School of Medicine, Chapel Hill. “It It will take some time for research to thaw,” she adds. McGill says she does not know of a single confirmed case of Covid-19 transmission through FMTs.

Bacteria 278

Bacteria Trials Research Medicine 278